Eastern Washington University

EWU Digital Commons
EWU Masters Thesis Collection

Student Research and Creative Works

2016

Determining the relationship between waist
circumference, BIA, and ultrasound
Austin Nelson
Eastern Washington University

Follow this and additional works at: http://dc.ewu.edu/theses
Recommended Citation
Nelson, Austin, "Determining the relationship between waist circumference, BIA, and ultrasound" (2016). EWU Masters Thesis
Collection. 375.
http://dc.ewu.edu/theses/375

This Thesis is brought to you for free and open access by the Student Research and Creative Works at EWU Digital Commons. It has been accepted for
inclusion in EWU Masters Thesis Collection by an authorized administrator of EWU Digital Commons. For more information, please contact
jotto@ewu.edu.

DETERMINING THE RELATIONSHIP BETWEEN WAIST CIRCUMFERENCE,
BIA, AND ULTRASOUND
________________________________________________________________________
A Thesis
Presented To
Eastern Washington University
Cheney, Washington
________________________________________________________________________
In Partial Fulfillment of the Requirements
for the Degree
Master of Science
________________________________________________________________________
By
Austin Nelson
Spring 2016

THESIS OF AUSTIN NELSON APPROVED BY

DATE
WENDY REPOVICH, GRADUATE COMMITTEE CHAIR

DATE
CARRI KREIDER, GRADUATE STUDY COMMITTEE

ii

MASTER’S THESIS
In presenting this thesis in partial fulfillment of the requirements for a master’s
degree at Eastern Washington University, I agree that the JFK Library shall make
copies freely available for inspection. I further agree that copying of this project
in whole or in part is allowable only for scholarly purposes. It is understood,
however, that any copying or publication of the thesis for commercial purposes,
or for financial gain, shall not be allowed with my written permission.

Signature
Date

iii

TABLE OF CONTENTS
Introduction ..................................................................................................................

1

Purpose Statement ................................................................................................

4

Hypothesis............................................................................................................

4

Operational Definition ..........................................................................................

4

Assumptions .........................................................................................................

5

Delimitations ........................................................................................................

5

Significance ..........................................................................................................

5

Review of Literature ....................................................................................................

6

Implications For Being Over Fat ..........................................................................

6

Measurements ....................................................................................................... 11
BMI ....................................................................................................................... 11
Waist Circumference ............................................................................................ 13
BIA ...................................................................................................................... 20
Ultrasound............................................................................................................. 23
Methods........................................................................................................................ 25
Participants ........................................................................................................... 25
Instrumentation ..................................................................................................... 26
Procedure .............................................................................................................. 26
Analysis ................................................................................................................ 28
Results ......................................................................................................................... 29
Discussion ................................................................................................................... 36
References …………………………………………………………………………… 42

iv

Appendices
Appendix 1 - IRB Approval ................................................................................. 49
Appendix 2 – Informed Consent........................................................................... 50
Appendix 3 – Data Collection Sheet .................................................................... 52
Vitae ............................................................................................................................. 53

v

Chapter 1
Introduction
The United States is facing an obesity epidemic due to more than 30% of the
population being above 30 on the BMI scale (CDC, 2009; Flegal, Ogden, & Curtin,
2010). No state met the Healthy People 2010 objective of less than 15% obesity
prevalence (CDC, 2009). Obesity prevalence has increased in Washington State steadily
from 1999 – 2009 by nearly a percentage point each year and the fastest growth rate for
obesity is between ages 18-34 (Washington State Department of Health, 2009).
Obesity and being overweight are associated with chronic diseases, including type
2 diabetes, cardiovascular disease, hypertension, and certain forms of cancer that result in
premature death (Washington State Department of Health, 2009; Williams, et al., 1992;
World Health Organization, 2003). Due to the relationship among cardiorespiratory
fitness, body composition, and physical activity, a person who develops one or more of
the previous diseases often will die sooner if they are obese compared to those who were
not obese (Lohman et al., 2008).
While obesity measured by BMI by is suggestive of risk, fat distribution appears
to be a more important variable than total body fat in terms of risk for cardiovascular
disease (Glaner, Lima, & Borysiuk, 2010). Because greater fat mass around the trunk
region is generally associated with this higher a measurement of the trunk region should
prove useful in screening people (Glaner, Lima, & Borysiuk, 2010). Both men and
women with higher waist to hip ratios have shown stronger associations to encounter
cardiovascular disease even when controlling for BMI, cancer and/or smoking (Hafe,

2
Pina, Tavares, & Barros, 2004, Lapidus et al., 1984; Larson et al., 1984; Oppert et al.,
2002).
Values of waist WC are consistently related to developing coronary heart disease
(CHD), while both the lowest and highest categories of WC remain significant after
adjustment for BMI for predicting CHD and diabetes (Klein et al., 2007). The WC
measurement itself is important and can be combined with BMI as The American College
of Sports Medicine in their Guidelines for Exercise Testing and Prescription (2010)
recommend combining a WC with BMI for the purpose of risk stratification. ACSM
acknowledges that BMI and WC can be used separately but still recommends using BMI
and WC when it is an option because abdominal obesity is a primary issue for being an
indicator of being at health risk (ACSM, 2010).
Abdominal adiposity has been designated as an independent cardiometabolic
disease risk factor (Janiszewski, Janssen, & Ross, 2007, Klein et al., 2007, & Ross et al.,
2008) among other risk factors such as age, hypertriglyceridemia, hypertension and high
fasting glucose, a group of risk factors that when combined increase risk exponentially,
called metabolic syndrome (Després, Lemieux, Bergeron, Pibarot, Mathieu, Laros et al.,
2008, Ford & Giles, 2003). Abdominal obesity is a risk factor because there is
subcutaneous fat (SAT) that is under the skin and deeper fat called visceral fat (VAT),
which surrounds the organs. The amount of visceral fat that can accompany abdominal
obesity is what puts a person at risk for metabolic syndrome. Every one-centimeter
incremental increase in waist circumference (WC) has shown increases of 6.8 cm2 of
visceral adipose tissue (VAT) in men and 3 cm2 of VAT in women, who have metabolic
syndrome (Onat et al., 2004).
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As an external measure, WC cannot distinguish between SAT and VAT, but
currently there are several measurement techniques that can, including Computed
Tomography (CT), Magnetic Resonance Imaging (MRI), and Ultrasound (US). VAT is
an important factor in screening for cardiometabolic disease risks and WC is an
affordable and time efficient alternative to CT, MRI, and US, to indirectly measure VAT
in people (Bosy-Westphal et al., 2010, Carr et al., 2004). Ultrasound has been shown to
be valid in older adults when compared to an MRI (Rolfe, et. al., 2010; Stolk, Wink,
Zelissen, Van Gils, & Grobbee, 2000). Tanita has the BC-418 Segment body
composition analyzer (Tanita, Tokyo, Japan) that has a trunk measure of percent body fat
estimation, which has been validated against dual energy x-ray absorptiometry (DEXA)
(Pietrobelli, Rubiano, St-Onge, & Heymsfield, 2004).
The American Heart Association (AHA), National Cholesterol Education
Program (NCEP), National Heart Blood and Lung Institute (NHLBI), National Institutes
of Health of Health (NIH) and the International Diabetes Foundation (IDF) all have WC
in their screening guidelines, and these organizations believe that WC should be used to
help screen people for risk of having or getting cardiometabolic disease (Carr et al., 2004;
Serviente & Sforzo, 2013). Unfortunately, these organizations and other organizations
there is no clear or consistent way to perform a WC measurement due to different
protocols using different sites for what is considered a person’s waist. The three main
sites used for WC are below the lowest rib, level at the umbilicus, and superior to the
iliac crest and the other two sites that can be used are minimal waist and midway between
the lowest palpable rib and the iliac crest (ACSM, 2010; Serviente & Sforzo, 2013). The
issue with different WC sites and one set of cut off points is that this leads to
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misclassification of people by placing more people in an at risk category due to the WC
at the level of the umbilicus when compared to minimal waist (Willis et al., 2007).
Obesity has become a problem that needs to be addressed in the United States.
Obesity itself is not as important as the abdominal obesity a person carries, more
particularly VAT. There are 5 different WC sites used with only one set of cut-off points
for all 5 WC sites (Serviente & Sforzo, 2013). No studies have tried to find a correlation
of VAT between WC and US or WC and BIA. If it is possible to determine which of the
various WC sites have the strongest correlation with a measure of VAT, than that site
could be the recommended measurement and could start a standardization protocol for
WC. Therefore, the purpose of this study is to assess if there is a correlation between any
of the three main WC sites and either BIA and/or ultrasound.
Hypothesis
H0: There will be no significant correlations between three waist circumference
sites: below the lowest rib; at the level of the umbilicus; and superior to the iliac crest;
with BMI; BIA trunk; or US VAT depth.
Ha: There will be a significant positive correlation between three waist
circumference sites: below the lowest rib; at the level of the umbilicus; and superior to
the iliac crest; with BMI; BIA trunk; and US VAT depth.
Operational Definitions
BIA: Trunk % fat was measured by the TANITA BC-418 Segmental Body
Composition Analyzer.
Body Mass Index: Body mass index (BMI), the ratio of height to weight was
determined using weight in kilograms divided by height in meters squared.
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SCAT & VAT: BodyMetrix portable ultrasound was used to assess SCAT, and
VAT depth.
Waist circumference: The three waist measurements, just below the lowest
palpable rib, at the level of the umbilicus, and superior to the iliac crest were
measured using a Gulick tape.
Assumptions
For body composition measurement with BIA, it is important that the subject is in
a rested and hydrated state. It is assumed that the subjects will refrain from exercise
24hrs prior to testing and normal fluid intake is maintained for accurate readings.
Delimitations
The population will be delimited to 72 subjects consisting of men and women ages 18 55 that were divided into groups of overweight, BMI score ≥ 26 kg/m2 to 29.9 kg/m2 and
a obese, BMI score ≥ 30 kg/m2.
Summary
This chapter presented the problem of obesity and the implications for being over fat in
the United States and how Washington State has been affected by the obesity problem
and more important than obesity is VAT depth. The primary purpose of this study was to
determine the relationship between waist circumference measurements and ultrasound
and BIA. Currently, there is no standard for waist circumference measurements. This
research was a step towards scientifically choosing an appropriate waist circumference
site.
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Chapter 2
Review of Literature
Introduction
The purpose of this research was to determine the relationship between waist
circumference measurements and ultrasound and BIA to help further research toward a
standard protocol for waist circumference measurements. A review of the current
literature will cover the implications and risks for being over fat and measurement issues
around obesity, and how WC may help with screening people for certain disease risk
factors.
Implications for being over fat
The need of effective interventions to reduce obesity and related health risks have
increased in recent decades due to obesity levels in adults and children have reached
epidemic proportions. The modern environment allows people easier access to make
unhealthy choices that result in an increased consumption of food, and reduced physical
activity. Population approaches for obesity, strive to promote energy balance and
physical activity (Kumanyika, Obarzanek, Stettler et al., 2008).

This all started in the

late 1980’s.
Between 1960 and 1974 the age adjusted prevalence of obesity only increased
1.1% using the National Health and Nutrition Examination Survey I (NHANES) data
(CDC, 2008). It was not until NHANES III took place from 1988-1994 that the first big
increase in obesity prevalence in the United States was found, which was an average
increase of 8% among men and women (Flegal, Ogden, & Curtin, 2010). This was
probably the beginning of the obesity epidemic in the United States. From 1980-2000
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obesity prevalence has more than doubled in the US. This is important because by 1980
obesity prevalence was estimated at 15% and by 1994 an 8 % increase was observed
bringing obesity prevalence to 23.2 %. The next increase (7.5%) lead to a 30.9% obesity
prevalence suggesting that the rate of obesity may be slowing down due to a lower
percentage increase than before (CDC, 2008; Flegal et al., 2010). Even though the
prevalence of obesity may be slowing down, the United States is still currently facing an
obesity epidemic due to more than 30% of the population being above 30 on the BMI
scale nationally, not one state met the Healthy People 2010 objective, which was to have
less than 15% obesity prevalence (CDC, 2009). Less than 15% obesity prevalence may
have been too big of a goal because by 2008 the age-adjusted prevalence of obesity (BMI
≥ 30.0) was 33.8% overall in the United States (Flegal et al., 2010). In Washington State
alone, obesity prevalence has increased steadily from 1999 – 2009 by nearly a percentage
point each year with the fastest growth rate for obesity in the age group 18-34 meaning
that the younger generation in Washington state could face bigger health problems and
higher health care cost if they do not take control over their obesity rate (Washington
State Department of Health (DOH), 2009).
The rising prevalence of obesity is important because there are implications that
go along with obesity. Obesity, and also being overweight are associated with chronic
diseases, including type 2 diabetes, cardiovascular disease, hypertension and high total
cholesterol, and certain forms of cancer that result in premature death (DOH, 2009;
Williams, et al., 1992; World Health Organization, 2003). There is a relationship that
exists between a person’s cardiorespiratory fitness, body composition, and physical
activity, and the relationship is, that a person who develops one or more of the previous
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diseases, often will die sooner if they are obese compared to those who are not obese
(Lohman et al., 2008). The prevalence of obesity may actually be higher than reported
because a lot of the population studies use self reported data (CDC, 2009).
In 2009, self reported body mass index scores (BMI) and body weight of
Americans lead to an obesity prevalence of 26.7% across America (CDC, 2009). That is
7.2 percentage points lower than the 2007-2008 NHANES report of 33.9% (CDC, 2009).
The discrepancy is probably from self-reported data versus actually measuring people for
accurate data.
Validity of self-reported height, weight, and BMI from the NHANES survey
from 2001-2006 was tested (Merrill & Richardson, 2009) and the results help explain
why the CDC report statistics that may have obesity prevalence predicted lower than it
may actually be. The researchers who tested the validity of self reported data found that
both men and woman over report their height increasingly at older ages. Men over report
their height by 1.22cm (0.48 in) and women over report height by .68cm (0.27 in). Men
have a tendency to overestimate their weight by .30kg (.66lbs) while women under
reported their weight by about -1.39 kg (-3.06 lbs) (Merrill & Richardson, 2009).
Although these examples appear to be minimal in values, over reporting height and
weight will have a direct impact on a BMI score. An example being that if a man
overestimates his height (about .5 inch) and weight (about .5lb) than a self reported 6’
male weighing 220.5lbs would have a BMI score of 29.9 placing him in the overweight
category when in reality he is 5’ 11.5” weighing 220lbs, his actual BMI score would be
30.3 placing him in the obese category. Male or female, if they are close to a cut off
point there is an opportunity for misclassification by self-reporting information.
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Mortality risk appears to vary by BMI categories. Using NHANES surveys, a
significant increase in all-cause mortality in the underweight and obese categories were
observed, while significant decrease in all-cause mortality was observed in the
overweight category when compared to the normal weight groups (Flegal, Graubard, &
Williamson, 2005). In a follow up study the authors estimated excess all-cause mortality
associations with underweight, overweight, and obesity in the United States using data
from the NHANES surveys (Flegal, Graubard, Williamson, & Gail, 2007). The follow
up involved information from the NHANES I, 1971-1975; II, 1976-1980; and III, 19881994, with mortality follow up through the year 2000, combined with underlying cause of
death information for 2.3 million adults 25 years and older from the 2004 vital statistics
data for the United States (Flegal et al., 2007). Mortality was split into cardiovascular
disease (CVD) mortality, cancer mortality and noncancer, non-CVD mortality.
In 2004 cardiovascular disease accounted for 37% of adult deaths in the United
States (Flegal et al., 2007). For CVD mortality, obesity, but not overweight, was
significantly positively associated with excess mortality. A person’s level of fitness
influences their body weight. Usually more active people have lower body weight or
body fat which is why higher levels of physical fitness appear to delay all-cause mortality
due primarily to lower rates of cardiovascular disease (Blair et al., 1989). During a
secondary analysis (Flegal et al., 2007) where CVD was split to coronary heart disease
(CHD) and deaths from other cardiovascular events including strokes, obesity was
significantly associated with increased mortality from both CHD (45,544 excess deaths;
95% CI, 24,785-66,303) and other forms of CVD (34,097 excess deaths; 95%CI,
213,848-54,346). Based on mortality rates of CVD cases, a person classified as over
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weight (BMI 25- < 30) maybe should not be instructed by healthcare professionals to lose
weight or gain any further weight.
Cancer accounted for approximately 24% of total deaths in adults in the United
States (Flegal et al., 2007). For cancer mortality there was little or no significant findings
or associations of excess mortality with any BMI category (Flegal et al., 2007)
Noncancer, non-CVD deaths accounted for approximately 39% of total deaths among
adults in the United States in 2004 (Flegal et al., 2007).
When the sample was split to underweight and obese, the underweight group of
the noncancer, non-CVD mortality category, was associated with significantly positive
number of excess deaths while the overweight group had a significantly negative number
of excess deaths. Jiang He and colleagues found similar results when they reported the
association between being underweight had an increased risk of death which remained
significant after exclusion of study participants who were current or former smokers;
those who had prevalent CVD, stroke, cancer, or end-stage renal disease; those who had
chronic obstructive pulmonary disease at the baseline examination; or those who died
during the first three years of follow-up (He et al., 2005). Obese groups were not
associated with any significant findings, positive or negative, in excess noncancer, nonCVD mortality. Having no cancer conditions and no CVD events and being underweight
(BMI < 18.5) a person may want to try to gain weight for decreased mortality especially
in women because underweight women had a higher relative risk of mortality than
underweight men but moderately/extremely obese women had a lower relative risk of
mortality than men in the same category (Flegal et al., 2007; He et al., 2005; Strawbridge,
Wallhagen, & Shema, 2000).
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People who rate on a cutoff point may think they are not endangered or at risk of
the diseases associated with being obese, which is why we need an accurate way to
measure adipose tissue (Flegal et. al. 2005). It is important not to put emphasis on
obesity because if you force the public or scare the public to lose weight they could place
themselves in harms way as they get older by trying to maintain low BMI scores
(Strawbridge et al., 2000).
Measurements
There are various measurement devices used in body composition research. Some
instruments are less expensive and also time efficient such as calculating a BMI score and
measuring WC which is relatively easy to do and can be completed in a variety of
settings. Other instruments, such as a bioelectrical impedance analysis (Tanita BC-418
Segmental Body Composition Analyzer) and a portable ultrasound (IntelaMetrix, Inc.,
Livermore, CA) are usually found in research settings and they cost more, not time
efficient, and require someone to administer the assessment which makes these options
less ideal for large populations.
BMI.
Body mass index (BMI) is an index that places a person in a classification of
weight status that varies from underweight to obese. The BMI calculation is weight in
kilograms divided by the square of height in meters (kg/m2). The calculation does not
use age or the gender of a person in the equation (CDC, 2008; WHO, 2008).
The various classifications of BMI are as follows; Underweight <18.50, Normal 18.5024.99, Overweight ≥25.00, Obese ≥ 30.00. The obese classification has three different
classes which are Obese class I 30.00-34.99, Obese class II 35.00-39.99 and Obese class
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III ≥ 40.00. The WHO has recognized and is still continuing research on the possibility
of establishing different cutoff points for different ethnic groups. The WHO is
responding to more evidence that suggest the association between BMI, body fat
distribution, and percentage of body fat may differ across different populations. The
focus has been on the breakpoint for the Overweight classification ≥ 25.00. Health risk
may increase below this cutoff due to populations who have lower body weights but
higher body fat percentages, for example Asian and Pacific Islander populations (WHO.
2004).
The WHO expert consultation team acknowledged the Pacific Islander population
as well for having a low proportion of fat mass to lean mass but still have some of the
highest rates of obesity in the world (WHO, 2004). The recommendation is that all
populations with a predisposition to central obesity and have an increased risk for
developing metabolic syndrome should include a waist circumference measurement as
well (WHO, 2004). Further research is needed to address BMI with waist circumference
in various populations to generate new standards. BMI has been combined with waist
circumference in the past.
BMI with Waist Measurement.
Using data from the 1999-2004 NHANES, researchers sought to see if WC could
in fact predict diabetes and cardiometabolic risk factors beyond that explained by BMI
alone (Janiszewski et al., 2007). After inclusion of BMI and cardiometabolic risk factors
and controlling for age, sex, race and smoking, WC still remained significant in medium
to high WC measurements for predicting diabetes in this population (Janiszewski et al.,
2007). The relation between WC and clinical outcome is consistently strong for diabetes
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risk, and WC is a stronger predictor of diabetes than BMI alone (Klein et al., 2007).
Values of WC are also consistently related to developing CHD, while both the lowest and
highest categories of WC remain significant after adjustment for BMI for predicting CHD
and diabetes (Klein et al., 2007).
BMI and waist circumference (WC) independently help with predicting body fat
on a person. Waist circumference has been correlated to total fat mass R2 = 0.87 women
and 0.68 for men but BMI has shown a stronger correlation with total fat mass R2 = 0.92
women and 0.78 for men (Janssen, Heymsfield, Allison, Kotler, & Ross, 2002). The
American College of Sports Medicine in their Guidelines for Exercise Testing and
Prescription (9ed) recommend combining a WC with BMI for the purpose of risk
stratification. ACSM acknowledges that BMI and WC can be used separately but still
recommends using BMI and WC when it is an option because abdominal obesity is a
primary issue for being an indicator of being at health risk (ACSM, 2010). No
organization has yet adopted a standard protocol for determining which WC should go
with BMI.
Waist Circumference.
Abdominal adiposity is a cardiometabolic disease risk factor (Janiszewski et al.,
2007; Klein et al., 2007; Ross et al., 2008) among other risk factors such as age,
hypertriglyceridemia, hypertension and high fasting glucose (Després et al. 2008, Ford &
Giles, 2003). Every 1cm increment in WC has shown increases of 6.8cm2 of VAT in
men and 3cm2 of VAT in women, who have metabolic syndrome (Onat et al., 2004). WC
compared to computerized tomography (CT) in women has shown that WC to intraabdominal fat volume had a correlation of 0.889 (Han, McNeil, & Lean, 1997). WC itself
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cannot distinguish between SAT and VAT but VAT is an important factor in screening
for cardiometabolic disease risks and WC is an affordable and time efficient alternative to
CT or MRI to indirectly measure visceral adipose tissue (VAT) in people (BosyWestphal et al., 2010, Carr et al., 2004).
Besides cardiometabolic disease, cardiovascular disease and type 2diabetes have
also been linked to high WC measurements. The population used was 5,882 people from
the NHANES III. Individuals with high WC were 73% more likely to have
cardiovascular disease than individuals with lower WC but after controlling for
cardiometabolic risk factors the interaction was not significant. After controlling for
cardiometabolic risk factors and including BMI, WC predicted type 2 diabetes in medium
to high WC measurements meaning that WC in this study predicted type 2 diabetes but
not cardiovascular disease (Janiszewski et al., 2007). Others have found that in both men
and women with higher waist to hip circumferences have shown stronger associations to
encounter CVD even when BMI, cancer, and smoking are controlled for (Lapidus,
Bengtsson, Larson, Pennert, Rybo, & Sjostrom, 1984; Larson, Svärdsudd, Welin,
Wilhelmsen, Björntorp, & Tibblin, 1984; Oppert, Charles, Thibult, Guy-Grand,
Eschwége, & Ducimetiére, 2002).
There is no consensus on the most appropriate WC measurement technique and
the American Heart Association (AHA), National Heart Blood and Lung Institute
(NHLBI), National Institutes of Health (NIH) and the International Diabetes Foundation
(IDF) all have WC in their screening guidelines. This causes confusion for exercise
professionals and allied health care workers as to which site and protocol to use or even if
it matters (Serviente & Sforzo, 2013) These organizations believe that WC should be
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used to help screen people for risk of having or getting cardiometabolic disease (Carr et
al., 2004, Serviente & Sforzo, 2013). Intra-abdominal fat has been independently
associated with all of the metabolic syndrome criteria (Carr et al., 2004). While they all
agree that WC should be done between these organizations there is no clear or definite
way to perform a WC measurement due to different protocols using different sites for
what is considered a person’s waist. The American College of Sports Medicine (ACSM)
has recommended one set of cut off points for WC measurements and they are >102 cm
for men and >88 cm for women which places them in a high risk category (ACSM,
2007). The downfall to these cut off points is that various organizations use different
sites to measure WC to obtain these measurements, causing either more people to be
placed at high risk or less people to be placed at high risk, depending on the site used.
WC current recommendations.
The WHO recommends that the WC measurement be made at the approximate
midpoint between the lower margin of the last palpable rib and the top of the iliac crest
(WHO, 2008). ACSM recommends using the narrowest part of the torso (ACSM, 2010).
The AHA, NHLBI and NIH recommend the point superior to the iliac crest (Cornier,
Després, & Davis, 2011, NHLBI, 1998, NIH, 2000). The IDF offers different cut off
points for various parts of the world but they offer no protocol to be used (IDF, 2006).
Difference between sites.
In terms of body fat and not disease risk, all five WC sites (measured at
immediately below the lowest rib, narrowest waist, midpoint between the lowest rib and
the iliac crest and immediately above the iliac crest) were compared to DEXA and found
that the WC site superior to the iliac crest had the highest correlation to total body fat in
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men and women (Wang et al., 2003). No matter which site is chosen, each WC
measurement appears to be reliable (Mason & Katzmarzyk, 2009).
When following specific instruction, there is good reliability for all measures.
Intraobserver reliability via intra class correlations were r = .989, r = 0.991, r = 0.992,
and r = 0.993 for the following WC sites in order; the narrowest part of the waist,
midpoint between the iliac crest, and below the lowest rib, at the level of the umbilicus,
and immediately above the iliac crest in 542 predominantly white men and women aged
20-67 years old (Mason & Katzmarzyk, 2009). Corresponding ICCs for interobserver
reliability were r = 0.989, r = 0. 987, r = 0.987, r = 0.987 suggesting the magnitude of the
WC measurement is influenced by the protocol chosen, more so in women than in men
(Mason & Katzmarzyk, 2009). In men and women the highest mean values have been
reported at the umbilicus site and the smallest mean at the narrowest (Mason &
Katzmarzyk, 2009). Similar results were found in 111 subjects using the same WC sites,
researchers determined that men measured at the narrowest part of the waist lead to a WC
mean that was significantly smaller than the other three sites, but females, the mean for
each site was significantly different from all other means from the other sites (Wang et
al., 2003). The various WC sites are reliable no matter which site is used, but the sites
themselves differ in magnitude and small differences are amplified when an exact cut off
point is used, rather than a continuum, to define abdominal obesity (Mason &
Katzmarzyk, 2009; Wang et al., 2003). It is important to take into consideration as to
which site to choose, otherwise you may have a conservative estimate or liberal estimate
(especially in women) who may be at risk for obesity and this is why adopting a standard
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measurement protocol will facilitate the interpretation and clinical utility of WC for
obesity-related risk stratification (Mason & Katzmarzyk, 2009)
Currently, major health organizations such as the NHLBI use the cut off points of
men WC ≥ 102cm and women WC ≥ 88cm (NHLBI, 1998). The controversy of these cut
off points is that they were developed using the WC site midway between the lowest rib
and the iliac crest (Lean, Han, & Morrison, 1995). NHLBI recommends using the WC
site superior to the iliac crest but uses cut offs that were developed from a different site
(NHLBI, 1998). The cut off points of men WC ≥ 102cm and women WC ≥ 88cm were
derived from a big sample (904 men & 1014 women) in Glasgow, Scotland and are based
on the association with BMI and WC (Lean et al., 1995). The research was for weight
management and the key messages were that most men with a waist circumference ≥ 102
cm and women with a waist circumference ≥ 88cm were appreciably overweight or had a
high waist to hip ratio and should be urged to lose weight and men with WC 94-102 cm
and women with a WC 80-88 cm should be careful to avoid more weight gain (Lean et
al., 1995). The practice of using cut off points based only on BMI and on one WC site
and interchangeably using those cut off points for other WC sites may lead to a lot of
misclassifications of people who may need to know if they are at risk of disease (Wang et
al., 2003).
With one set of cut off points for all five WC sites, using the various WC sites
could lead to misclassification of obesity. In men and women the highest mean values
have been reported at the umbilicus site and the smallest mean at the narrowest waist so
using these sites your (Mason & Katzmarzyk, 2009).
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An example of misclassification of health risk is a study that compared the minimal waist
and the umbilical sites (Willis et al., 2007). Instead of using BMI (Lean et al., 1995)
researchers used intravenous glucose tolerance test, fasting plasma lipid analysis and
computed tomography scans were conducted. In both men and women the minimal waist
site had stronger correlations to cardiovascular disease risk factors and metabolic
syndrome than the umbilicus site. Using the Adult Treatment Panel (ATP) III criteria
and using the cut off points of men WC ≥ 102cm and women WC ≥ 88cm, the site used
made a difference. Using the umbilical site with these cut off points, it placed 54% more
men and 68% more women at or above the cut off points (Willis et al., 2007).
Comparing umbilicus, midpoint between the lowest rib and the iliac crest,
superior to the iliac crest and minimal waist sites, to find out if a measurement site will
affect cardiometabolic risk classification using the cut off points of men WC ≥ 102cm
and women WC ≥ 88cm (Lean et al., 1995), researchers tested each of these sites for
sensitivity and specificity (Mason & Katzmarzyk, 2010). In both sexes, WC at the
umbilicus showed greater sensitivity but less specificity meaning better at predicting the
presence of disease and not as good as showing absence of disease. (Mason &
Katzmarzyk, 2010, Serviente & Sforzo, 2013). Measurements at the minimal waist
showed less sensitivity but greater specificity at detecting ≥ 2 risk factors for
cardiometabolic disease. Using the widely accepted cut off points of men WC ≥ 102cm
and women WC ≥ 88cm (Lean et al., 1995), the magnitude of WC is affected by the
measurement site chosen. Using minimal waist for the men, only placed 23% of them
into high health risk (>102 cm) while using the umbilicus site, 34% of the men met >102
cm. In women 31% were > 88cm and using the minimal waist site and the umbilicus site
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placed 55% of the women above 88 cm (Mason & Katzmarzyk, 2009). This variation
demonstrates the need to have a single WC measurement site and cut off points to go
with that site to classify people in a health risk category.
As far as choosing the site to pick for standardization protocol for WC there is an
even bigger debate than interchanging cut off points for different sites. Currently there is
no agreement on the absolute best site for WC (Serviente & Sforzo, 2013). Three WC
sites (below the lowest palpable rib, superior to the iliac crest and midway between the
lowest rib and the iliac crest) have been tested to see if a site is better than another based
on volume of VAT and SAT from a MRI, along with cardiometabolic risk factors such as
blood pressure, plasma lipids, homeostasis model (HOMA index) and glucose (BosyWestphal et al., 2010). After a dietary intervention, below the lowest palpable rib was
the only site that predicted weight loss associated with a decrease in VAT, but in women
only. The site superior to the iliac crest had very low association with VAT and
cardiometabolic risk factors in women. In men and children all three sites had similar
relations to VAT, SAT and cardiometabolic risk factors (Bosy-Westphal et al., 2010).
The site below the lowest palpable rib showed the best correlations to pick a site for both
sexes in terms of total VAT and cardiometabolic risk factors (r = 0.74 men, r = 0.70 in
women) and men midway between the lowest palpable rib and the iliac crest had similar
results as the lowest palpable rib site (Bosy-Westphal et al., 2010).
In men CT has shown that at L1-L2 and L2-L3 have significantly higher
correlations (R2 = 0.96, P < 0.05) with total volume of fat and lower SEEs than all other
images taken by CT scans from T11-S1 (Kuk, Church, Blair, & Ross, 2006). Women
that were measured at the midway between the lowest rib and the iliac crest were
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compared to MRI and CT scans and 2/3 of the distance instead of midway showed r =
0.99 for predicting intra-abdominal fat (Han et al., 1997). These previously described
studies give evidence to the need to identify the best site of WC to predict disease risk.
Although WC has been shown to be highly reliable across all sites and WC has a
strong correlation to body fat, cardiovascular disease and metabolic syndrome risk factors
there is still no standard protocol and some WC measurements may miss classify more
people than other WC sites (Klipstein-Grobusch, Georg, & Boeing, 1997; Mason &
Katzmarzyk, 2010, & Wang et al., 2003; Willis et al., 2007). VAT is an important factor
in screening for cardiometabolic disease risks and WC is an affordable and time efficient
alternative to CT or MRI to indirectly measure VAT in people (Bosy-Westphal et al.,
2010, Carr et al., 2004). There are other instruments that can measure the trunk region as
well.
BIA.
Bioelectrical Impedance Analysis (BIA) is a noninvasive method that is used to evaluate
a person’s body composition. BIA measures the bioelectrical impedance of the body by
applying a low-level electrical current through the body. The Tanita Body Composition
Analyzer uses a high frequency constant current (50kHz, 500uA). Fat mass allows
minimal electrical current to pass through where as water allows electrical current to flow
through with little resistance, especially in the human body where the water content tends
to hold electrolytes which are also great conductors of electricity (Heyward & Wagner,
2004). The electrical resistance measured or impedance, measured in BIA is the
difficulty with which electricity passes through the body. Body fat percentage, muscle
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mass and total body water can be inferred by measuring the electrical resistance of the
body.
BIA has seen a lot of changes in the last 25 years due to technological advances.
The original BIA method, which is still used, involves placing electrodes at the wrist and
ankles. This method alone has opened up numerous research opportunities involving
standardizing placement of electrodes, various frequency’s used, and the errors associated
with subjects in various hydration states (Baumgartner, Chumlea, & Roche, 1989,
Houtkooper, Lohman, Going, & Howell, 1996). In one study, the original style BIA with
applied electrodes was used and still good correlations (r = 0.88) were found to computed
tomography (CT) (Ryo et al., 2005).
The first non-clinical method involved a lower body analyzer made available for
home use in 1992 (Heyward & Wagner, 2004). Leg to leg BIA devices have shown to be
more reliable than hand held versions when compared to Air Displacement
Plethysmography (ADP) (Peterson, Repovich & Parascand., 2011). Some devices such as
the BIA 310 (Biodynamics, Seattle) are portable devices where an electrode is wrapped
around the wrist and the ankle, and this method has been validated to ADP, and
hydrostatic weighing (HW) (Biaggi et al., 1999). The next method developed by Omron
Healthcare, was a handheld upper body BIA device created in the 1990s for home use
(Heyward & Wagner, 2004). Various companies that made the lower body analyzers
also manufactured full body analyzers where a person stands on electrode plates while
holding a handle, which also contain electrodes in each hand, and a segmental BIA
(SBIA) reading is given in addition to the whole body composition value. Recently,
Tanita has manufactured the BC-418 Segment body composition analyzer (Tanita,
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Tokyo, Japan) which is a multi frequency octo-polar model, which has been validated
against dual energy x-ray absorptiometry (DEXA) (Pietrobelli et al., 2004). Multi
frequency octo-polar models have shown to be in closer agreement to DEXA than single
frequency eight electrode models and single frequency four-polar electrode models
(Demura, Sato & Kitabayashi., 2004). In one study it was reported that a multi frequency
BIA with eight electrodes displayed a difference in which men had an over estimation of
percent total body fat and women were underestimated in percent total body fat but there
still was not a significant difference between DEXA or hydrostatic weighing (Demura, et
al., 2004). It is unclear if there is a sex characteristic or degrees of obesity responsible for
the over estimation of body fat percentage in men, and the under estimation of body fat
percentage in women from the octopolar model (Demura, et al., 2004).
Being obese or severely obese has been discussed as being a limitation when
using BIA, which has consistently overestimated lean body mass in severely obese
people (Segal, Loan, Fitzgerald, Hodgdon & Itallie, 1988). This could be due to the fact
that impedance is proportional to length and inversely proportional to diameter so a
severely obese person who may have more hydration especially in the trunk region due to
being obese and is going to have a low impedance reading for the trunk and the total
body water may be shown lower than what it really is (Deurenberg, 1996) even though
the trunk has been shown to contribute about 10 percent of total impedance for the whole
body (Bracco et al., 1996). Over hydration of fat free mass and body shape may be what
causes FFM to be overestimated and therefore body fat is than under estimated. As long
as a person is in a normal hydrated state for accurate readings, BIA has been effective at
estimating total body fatness and segmental body fatness when compared to other clinical
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methods (Peterson et al., 2011; Pietrobelli et al., 2004; Ryo et al., 2005). All of these
methods rely on the same principles and all are subject to the same validity issues and
limitations. BIA like other methods in body composition research has limitations.
Quantity and distribution of water within the human body may cause the impedance to
change. When a person decides to use a BIA device it is important to be at a normal
hydrated state (Heymsfield, Wang, Visser, Gallagher, & Pierson Jr, 1996; Houtkooper,
1996). Exercise may leave a person in a dehydrated state and food intake all have an
effect of causing the electrical resistance to be inaccurate, thereby allowing for inaccurate
BIA readings (Houtkooper et al., 1996).
Ultrasonography.
The basic technology of ultrasound or ultrasonography requires the human body
to be exposed to high-frequency sound waves which in turn, produce an image of the
inside of the body. Ultrasound (US) is a relatively new method used in body composition
research, and recently a portable US has arrived on the market to measure SAT and VAT
(Ulbricht et al., 2012). When comparing results to other body composition measurement
tools in a variety of populations, strong correlations were found (Johnson, Naccarato,
Corder, & Repovich, 2012; Pineau, & Bocquet, 2009; Ribeiro-Filho, Faria, Azjen,
Zanella, & Ferreira, 2003; Rolfe, et. al., 2010; Stolk et al., 2001). Even while on a
restricted diet similar results have been reported with adolescents between ultrasound and
DEXA after a six-month weight loss program (r = 0.95) (Pineau et al., 2010). In addition
to measuring body composition, a secondary benefit of US is the ability to measure VAT.
The ability of US to assess VAT has been validated against other measurement tools
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(Johnson et al., 2012; Ribeiro-Filho et al., 2003; Rolfe, et. al., 2010; Rolfe, et al., 2011;
Stolk et al., 2001).
Summary
The obesity epidemic is relevant to the work force and many organizations and
companies have started programs to help address the epidemic. Since many
organizations are attempting to approach the obesity epidemic, easy to use, reliable and
valid methods need to be implemented to measure many people. Clinical assessment
methods are not accessible by the public and are expensive. Due to cost and access, field
measurements are commonly used to make measurements and estimates of body
composition in order to help people identify where they fall in terms of weight and
obesity.
Simple field measurements like BMI and WC measurements have been useful due
to low cost and efficiency. Ultrasound is available to the public in an affordable form
and ultrasound has been shown to be valid in older adults when compared to an MRI.
Both men and women with higher waist to hip circumferences have shown stronger
associations to encounter CVD even when BMI, cancer and smoking are controlled for.
Excessive trunk fat due to obesity is a risk factor for cardiovascular disease and WC is a
simple screening tool that can be implemented. Currently, there is no one protocol or
WC site that is a standard. WC and ultrasound have not been tested to see if a correlation
may exist in visceral fat depth and the various WC sites to help determine if a site may be
a better choice over another site.
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Chapter 3
Methods
The purpose of this study was to compare waist circumference sites to ultrasound
and BIA. Specifically to see if a relationship exist between visceral fat depth from
ultrasound and the trunk measure from the BIA to the three different waist
circumferences used. This chapter provides a description of the methodology that was
used to test the hypotheses for the current study. This chapter provides a background of
the participants, information on the instrumentation, an overview of the procedures, and a
description of the statistical analyses that will be performed.
Participants
The participants consist of men and women within the ages of 18-55 and were
divided by an overweight group with at least a BMI score ≥ 26 kg/m2 and an obese group
with a BMI score of ≥ 30. The participants were recruited through flyers and word of
mouth from around and in Eastern Washington University and the surrounding
community. Table one features descriptive statistics.
Table 1. descriptive Statistics for the entire sample and subgroups.
Variable
Age
Height
(in)
Weight
(lbs)
BMI

ALL

Men

n = 72
22.8 ±
5.2
66.2 ±
4.1
202.1 ±
40.6
31.7 ±
5.7

n = 33
23.6 ±
3.5
70.1 ±
3.1
219.9 ±
28.5
31.4 ±
3.8

Men
Overweight
n = 16
23.5 ±
2.8
70.1 ±
3.9
201.8 ±
20.8
28.5 ±
0.1

Men
Obese
n = 17
23.7 ±
4.1
69.9 ±
2.3
237.0 ±
24.1
34.1 ±
3.6

Women
All
n = 39
22.2 ±
6.3
64.1 ±
2.5
187.0 ±
43.4
31.9 ±
6.9

Women
Overweight
n = 23
20.6 ±
1.4
64.0 ±
2.5
165.4 ±
17.1
28.3 ±
1.2

Women
Obese
n = 16
24.4 ±
9.4
64.2 ±
2.5
218.2 ±
50.9
37.20 ±
8.2
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Instrumentation
The following variables were recorded for each participant in order to conduct
this study: age, gender, height, weight, BIA segment analysis of the trunk, ultrasound
visceral fat depth, and three standard waist circumference measurements in cm.
Anthropometric measurements of height in inches were taken using a beam scale
equipped with a level (Detecto Physician Scale, Cardinal Scale Manufacturing Co., Webb
City, MO). Waist circumference was measured using a Gulick tape measure. A multifrequency BIA (Tanita BC-418 Segmental Body Composition Analyzer) was used for an
assessment of % fat in the trunk. Visceral and subcutaneous fat levels were measured
with a BodyMetrix (IntelaMetrix, Inc., Livermore, CA) portable ultrasonography
machine.
Procedure
After obtaining approval from Eastern Washington University’s Institutional
Review Board, recruitment started. Testing was administered in the Human Performance
Lab. Once the person agreed to be a participant, height and weight were self-reported to
find their BMI score, to assure they match the standard body composition of BMI ≥ 26.
Once they were prescreened, they were scheduled for testing. All subjects turned in the
signed informed consent at the testing session.
To verify BMI score, height was measured on the standiometer (Detecto
Physician Scale, Cardinal Scale Manufacturing Co., Webb City, MO) Next, BIA trunk fat
%, BMI, and body weight in pounds were measured and calculated by the TANITA BC418. The principle investigator entered the subjects’ age, body type (standard for all
subjects) and height from standiometer reading. The subjects were instructed to step onto
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the BIA device bare foot, covering the feet plates to have their body composition
assessed. When the BIA was set up with the subjects information, the principle
investigator instructed the subject to abduct their arms while holding the hand held
attachments and covering the metal inserts in the handles, while the reading takes place.
After the measurements were made, the subject replaced the handle attachments and
stepped off of the BIA device. All body composition data was made available to the
subject at the time of testing and after all the data was collected.
Following BIA procedures, the subjects underwent three different waist
circumference measurements. Subjects were instructed to have their abdominal area to
be accessible for the principle investigator. The first waist circumference measurement
was below the lowest palpable rib. The lowest rib was palpated to ensure location of the
landmark. Once the landmark was located, the principle investigator wrapped a Gulick
tape measure around the subject’s abdomen at that level while making sure the tape
remained flat all the way around the subject. The tension bar was pulled, the
measurement was recorded rounded to the nearest .5cm and recorded on a separate data
collection sheet. The procedure was repeated for the second waist circumference
measurement taken at the level of the umbilicus. The last waist circumference
measurement was taken superior to the iliac crest following the same procedure. After all
three waists circumferences were recorded, the principle investigator repeated all three
measurements in the same order to ensure reliability. After the second round of
measurements, if any site was not within .5cm, additional measurements were taken until
two readings were within .5cm, and an average was computed for the final reading used.
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The last procedure was an ultrasound scan of the abdomen using the BodyMetrix
portable ultrasound device. The Ultrasound gel is used to enhance conduction for the
ultrasound wand. To perform the ultrasound reading to assess visceral and subcutaneous
fat levels, the gelled wand was placed on the abdomen perpendicular and 1cm to the right
side of the umbilicus. Slowly moving the wand 7-10 cm towards the hip completed the
abdomen scan. The software included with the BodyMetrix device does not calculate the
measurement depths for visceral and subcutaneous fat but the tissue types were visible on
the accompanied computer screen. The greatest depth was determined by the principle
investigator and recorded on the data sheet.
Analysis
Statistical analysis was performed using SPSS version 23 (SPSS Inc., Chicago,
IL). Data was screened for outliers. Descriptive statistics were reported including the
subject’s age, BMI, BIA, height, VAT, waist circumference sites, and weight. The
results are presented in table 1. Pearson’s r correlations were used to determine the
relationship that exists between the three different waist circumference measurements and
BMI, BIA, and ultrasound.
Summary
The purpose of this experiment was to compare waist circumference sites to
ultrasound and BIA. Specifically to see if a relationship exist between visceral fat depth
from ultrasound and the trunk measure from the BIA to the three different waist
circumferences. This chapter presented the methods and statistical analysis used in the
study.
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Chapter 4
Results
The purpose of this study was to see if a relationship might exist between the
visceral fat depth from ultrasound and the trunk measure from the BIA to the three
different waist circumferences used. This chapter provides a summary of the results from
the statistical analysis depicted in the previous chapter.
Descriptive Statistics
After recruitment 255 people responded. After prescreening only 75 participants
completed testing. Three participants did not meet the criteria on day of testing so they
were excluded leaving the total sample size to n = 72. The means and standard
deviations for the descriptive statistics are displayed in Table 1.
Pearson’s Correlation
The sample was broken down into overweight (BMI ≥ 26.0 – 29.0) and obese (≥ 30.0)
groups for each gender. Table 2 contains the r values for the entire sample.
Table 2. entire sample r values, n = 72.
Variable
WC1
WC1
WC2
.904**
WC3
.208
BMI
.843**
BIA
.166
US
.253*
*p < .05, **p < .01

WC2
.904**
.241*
.862**
.415**
.531**

WC3
.208
.241*
.162
.155
.196

BMI
.843*
.862**
.162
.418**
.407**

BIA
.166
.415**
.155
.418**
.693**

US
.253*
.531**
.196
.407**
.693**
-

BMI showed a strong significant correlation to WC1 (r = .843, p = < .01) and WC2 (r =
.862, p = < .01). BMI had little relationship to WC3. BMI had significant but low
correlations to BIA (r = .418, p = < .01) and US (r = .407, p = < .01). BIA had a
significant but low correlation (r = .415, p = < .01) to WC2. WC1 and WC3 had no
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correlations to BIA. Only WC2 (r = .531, p = < .01) had a significant moderate
correlation to ultrasound. The H0 is rejected for BMI to WC1 and WC2 and accepted for
WC3. For BIA the H0 is rejected for WC2 and accepted for WC1 and WC3. For US the
H0 is rejected for WC1 and WC2 and accepted for WC3. When the sample was than
broken down into overweight (BMI ≥ 26.0-29.9) and obese (≥ 30) groups. Table 3
contains the r values for the overweight group that contains males and females.
Table 3. overweight (BMI ≥ 26.0-29.9) men and women for the entire sample, n = 39
Variable
WC1
WC2
WC3
BMI
BIA
US
WC1
.739**
.754**
.495**
-.876
-.221
WC2
.739**
.954**
.571
.251
.350*
WC3
.754**
.954**
.534**
.145
.289
BMI
.495**
.571**
.534**
.256
.136
BIA
-.187
.251
.145
.256
.727**
US
-.221
.350*
.289
.136
.727**
*p < .05, **p < .01
BMI had a significant but low correlation to WC1 (r = .495, p = < .01) and significant but
moderately correlated to WC2 and WC3 sites (WC2 r = .571, p = < .01, WC3 r = .534, p
= < .01). BIA showed a significant and high correlation (r = .727, p = < .01 to US. Only
WC2 showed a significant but low correlation (r = .350, p = < .05) to US. For BMI the
H0 is rejected for all three WC sites. For BIA the H0 is accepted for all three WC sites.
For US the H0 is rejected for WC2 and accepted for WC1 and WC3. The BMI and WC 2
should be used together. Table 4 shows the obese group for the entire sample.
Table 4. all obese (BMI ≥ 30) people of the entire sample, n = 33
Variable
WC1
WC1
WC2
.879**
WC3
.107
BMI
.853**
BIA
.345*
US
.240
*p < .05, **p < .01

WC2
.879**
.153
.867**
.609**
.518**

WC3
.107
.153
.042
.205
.173

BMI
.853**
.867**
.042
.640**
.349*

BIA
.345*
.609**
.205
.640**
.692**

US
.240
.518**
.173
.349*
.692**
-
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WC1 (r = .853, p = < .01) and WC2 (r = .867, p = < .01) were the only sites strongly
correlated to BMI. BIA had a significant but low correlation (r = .345, p = < .05) to WC1
and WC2 had a significant but moderate correlation (r = .609, p = < .01). US to WC2
had the only correlation and it showed a significant but moderate correlation (r = .518, p
= < .01). For BMI the H0 is rejected for WC1 and WC2 and accepted for WC3. For BIA
the H0 is rejected for WC1 and WC2 and accepted for WC3. For US the H0 is rejected for
WC2 and accepted for WC1 and WC3. Next the data was separated by gender. Table 5
shows the r values for the males as one group.
Table 5. all males, n = 33
Variable
WC1
WC1
WC2
.956**
WC3
.956**
BMI
.868**
BIA
.867**
US
.686**
*p < .05, **p < .01

WC2
.956**
.983**
.858**
.869**
.779**

WC3
.956**
.983**
.876*
.857**
.785**

BMI
.868**
.858**
.876**
.759**
.669**

BIA
.867**
.869**
.857**
.759**
.721**

US
.686**
.779**
.785**
.669**
.721**
-

BMI was significant and highly correlated to all three WC sites (WC1 r = .868, p = < .01,
WC2 r = .858, p = < .01, WC3 r = .876, p = < .01). All three WC sites (WC1 r = .867, p
= < .01, WC2 r = .869, p = < .01, WC3 r = .857, p = < .01) were significantly and highly
correlated to the BIA. WC1 (r = .686, p = < .01) had a significant but moderate
correlation to US. WC2 (r = .779, p = .01) and WC3 (r = .785, p = < .01) show
significant and highly correlated to US. For BMI, BIA, and US, the H0 is rejected in all
three WC sites. All the males were than broken down into the underweight (BMI ≥ 2629.9) category and obese (BMI ≥ 30) category. Table 6 shows the r values for the
overweight category for males only.
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Table 6. all overweight (BMI ≥ 26-29.9) males, n = 16
Variable
WC1
WC1
WC2
.929**
WC3
.951**
BMI
.336
BIA
.705**
US
.543*
*p < .05, **p < .01

WC2
.929**
.956**
.388
.736**
.673**

WC3
.951**
.956**
.324
.742**
.637**

BMI
.336
.388
.324
.232
.096

BIA
.705*
.736**
.742**
.232
.700**

US
.543*
.673**
.637**
.096
.700
-

BMI had no significant and low correlations to all three WC sites. BIA showed a highly
significant relationship to all three WC sites (WC1 r = .705, p = < .01, WC2 r = .736, p =
< .01, WC3 r = .742, p = < .01). All three WC sites (WC1 r = .543, p = < .01, WC2 r =
.673, p = < .01, WC3 r = .637, p = < .01) had significant but moderate correlations to US.
For BMI the H0 is accepted for all three WC sites. For BIA and US the H0 is rejected for
all three WC sites. Table 7 shows the r values for obese (BMI ≥ 30) males.
Table 7. all obese (BMI ≥ 30) males, n = 17
Variable
WC1
WC1
WC2
.930**
WC3
.920**
BMI
.931*
BIA
.900**
US
.620**
*p < .05, **p < .01

WC2
.930**
.986**
.907**
.879**
.760**

WC3
.920**
.986**
.893**
.846**
.780**

BMI
.931**
.907**
.893**
.866**
.640**

BIA
.900**
.879*
.846**
.866**
.692**

US
.620**
.760**
.780**
.640**
.692**
-

BMI was high to very highly correlated (WC1 r = .931, p = < .01, WC2, r = .907, p = <
.01, WC3 r = .893, p = < .01) to all three WC sites. BIA to WC1 was significant and
very highly correlated (r = .900, p < .01). WC2 (r = .879, p = < .01) and WC3 (r = .846, p
= < .01) had significantly high correlations to BIA. Moderate to high significant
correlations were found between all three WC sites (WC1 r = .620, p < .01, WC2 r =

33
.760, p = < .01, WC3 r = .846, p = < .01) to US. The H0 is rejected for BMI, BIA, and US
for all three WC sites. Table 8 displays the r values for the females as one group.
Table 8. all females, n = 39
Variable
WC1
WC1
WC2
.956**
WC3
.270
BMI
.933**
BIA
.516**
US
.585**
*p < .05, **p < .01

WC2
.956**
.257
.879**
.508**
.631**

WC3
.270
.257
.150
.106
.178

BMI
.933**
.879**
.150
.486**
.415**

BIA
.516**
.508**
.106
.486**
.370*

US
.585**
.631**
.178
.415**
.370*
-

WC1 (r = .933, p = < .01) and WC2 (r = .879, p = < .01) were significant and very high
and highly correlated to BMI. WC1 (r = .516, p = < .01) and WC2 (r = .508, p = < .01)
were significant and moderately correlated to BIA. WC1 (r = .585, p = < .01) and WC2
(r = .631, p = < .01) were significant but moderately correlated to US. For BMI, BIA,
and US the H0 is rejected for WC1 and WC2. For BMI, BIA, and US the H0 is accepted
for WC3. BMI with WC1 or WC2 can be used together. Overweight (BMI ≥ 26 – 29.9)
female group r values are presented in table 9.
Table 9. all overweight (BMI ≥ 26-29.9) females, n = 23
Variable
WC1
WC1
WC2
.865**
WC3
.845**
BMI
.740**
BIA
.507*
US
.584**
*p < .05, **p < .01

WC2
.865**
.953**
.675**
.420*
.674*

WC3
.845**
.953**
.638**
.257
.604**

BMI
.740**
.675**
.638**
.546**
.417**

BIA
.507*
.420*
.257
.546*
.396

US
.584**
.674**
.604**
.417*
.396
-

WC1 (r = .740, p = < .01) showed a significant high correlation to BMI. WC2 (r = .675,
p = < .01) and WC3 (r = .638, p = < .01) were significantly but moderately correlated to
BMI. WC2 (r = .420, p = < .05) had a significant but low correlation to BIA, while WC1
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(r = .507, p = < .05) had a significant but moderate correlation to BIA. All three WC
sites (WC1 r = .584, p = < .01, WC2 r = .674, p = < .01, WC3 r = .604, p = < .01) had a
significant but moderate correlation to US. For BMI the H0 is rejected for all three WC
sites. For BIA the H0 is rejected for WC1 and WC2 but accepted for WC3. For US the
H0 is rejected for all three WC sites. Table 10 shows the r values for the obese (BMI ≥
30) female group.
Table 10. all obese (BMI ≥ 30) females, n = 16
Variable
WC1
WC1
WC2
.943**
WC3
.135
BMI
.927**
BIA
.721**
US
.305
*p < .05, **p < .01

WC2
.943**
.117
.881**
.713**
.312

WC3
.135
.117
-.022
.081
.062

BMI
.927**
.881**
-.022
.778**
.111

BIA
.721**
.713**
.081
.778**
.167

US
.305
.312
.062
.111
.167
-

WC1 (r = .927, p = < .01) was significant and very highly correlated to BMI and WC2 (r
= .881, p = < .01) was significant and highly correlated to BMI. WC1 (r = .721, p = <
.01) and WC2 (r = .713, p = < .01) were significantly highly correlated to BIA. All three
WC sites had non-significant low relationships to US. WC3 had non-significant and low
relationship with all variables. For BMI and BIA, the H0 is rejected for WC1 and WC2
but accepted for WC3. For US the H0 is accepted for all three WC sites. BMI with WC1
or WC2 can be used together.
Summary
For BMI the sample as an entire group and all the male categories should utilize
BMI with WC2. Females as a group or broken down to categories can use BMI with
WC1 or WC2.
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The sample as one group WC2 was the only site to have a significant moderate
relationship to US so WC2 should be used for a group. For males WC2 works with all
males, overweight and obese males, but WC3 had a slightly larger correlation to obese
males and males as an entire group. For females as a group and as the overweight
category, WC2 should be utilized. In the female obese group, there was no significant
relationship to any of the variables. WC2 appears to be the best WC measurement
overall for this sample.
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Chapter 5
Discussion
The main purpose of this study was to see if a relationship existed between the
visceral fat depth from an ultrasound measurement and the trunk measure from BIA to
the three different waist circumference sites used. This chapter discusses the results from
this study as they relate to the current literature.
Results
For the population as a group, WC1 showed no correlation to US which is in
disagreement with other authors who claim that WC taken at the lowest palpable rib
(WC1) may be best for identifying cardiometabolic disease risk based on VAT deposition
patterns (Serviente & Sforzo 2013,Willis et al., 2007). In this study WC just below the
lowest palpable rib showed a significant but no correlation (r = .253, p < .05) to US and a
non-significant (r = .166) relationship to BIA. WC2 at the level of the umbilicus had the
highest correlation (r = .862, p = < .01) to BMI and WC2 was the only one of the three
sites to have a significant but low correlation (r = .415, p = < .01) to BIA and a
significant but moderate correlation (r = .531, p = < .01) to US in this sample n = 72.
WC2 is also not recommended by many organizations such as ACSM, AHA, NHLBI,
NIH and the WHO (ACSM, 2010; Cornier et al., 2011; IDF, 2006; NHLBI, 1998; NIH,
2000; WHO, 2008). WC2 was also the only WC site to have a significant but low
correlation (r = .415, p < .01) to BIA in the same sample n = 72. In this study WC just
below the lowest palpable rib showed a significant but no correlation (r = .253, p < .05)
to US and a non-significant (r = .166) relationship to BIA.
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When the sample is broken down to overweight and obese categories the
overweight group for BMI should be paired with WC2 due to having the highest
correlation (r = .571, p = < .01) and again WC2 had the only significant but low
correlation (r = .350, p = < .05) to US. For an overweight population it appears that the
level of the umbilicus (WC2) should be used which again is not recommended by a few
major organizations. The obese group for BMI also had WC2 being the best match with
highest correlation (r = .867, p = < .01) and BIA (r = .609, p = < .01) and US r = .518, p
= < .01) as well. BIA also had the most significant but still moderate correlation (r =
.609, p = < .01) to WC2 in the all obese group, which are in a disagreement with Segal et
al., 1988 who claim being obese or severely obese is a limitation when using BIA
because it consistently overestimated lean body mass in severely obese people. This may
still be true for total body fat estimation but for trunk estimation BIA in an obese
population had the strongest agreement with US.
The all males group BMI should be paired with superior to the iliac crest (WC3)
or WC2, which WC3 is in agreement with ACSM, AHA, and the NIH recommendations.
BIA appears to work well in estimating trunk fat percentage at all three WC sites. WC2
(at the level of the umbilicus) and WC3 (superior to the iliac crest) had significant high
correlations to US (WC2 r = .779, p = < .01, WC3 r = .785, < .01) that again agree with
ACSM, AHA, and the NIH recommendations in regards to choosing superior to the iliac
crest. All three WC sites had moderate significant correlations in the male combined
sample (WC1 r = .686, p = < .01; WC2 r = .779, p = < .01; WC3 r = .785, p = < .01).
This is in agreement with Kuk et al., 2006 who only had a male sample and CT scans
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from Lumbar 1- Lumbar 3 showed the highest correlation (R2 = 0.96, P < 0.05) with
total volume of fat and lower SEEs than all other images taken by CT scans from T11-S1.
When the all male sample is broken down into overweight and obese categories
the overweight category had no significant correlations with any three WC sites but all
relationships were low. BMI can be used with any of these three WC sites but note only
a low relationship was found. BIA had similar correlations for all three WC sites, which
agrees with Segal et al., 1988 whom claim obese or severely obese is a limitation when
using BIA and in this overweight sample BIA relationships are similar in all 3 WC sites.
WC2 and US had the strongest and significant correlation (WC2 r = .736, p = < .01) so
WC2 is recommended for overweight males. For obese males BIA had a very high and
significant correlation to WC1 (r = .900, p = < .01) and high correlations to WC2 (r =
.879, p = < .01) and WC3 (r = .846, p = < .01). These results are in disagreement with
Segal et al., 1988 who claim being obese or severely obese is a limitation when using
BIA because it has consistently overestimated lean body mass in severely obese people.
For a dominant male sample maybe a lower WC measurement would be better. This
could be due to males tending to develop android obesity.
The all female group also had WC2 having the highest significant moderate (r =
.631, p = < .01) correlation to US.
WC3 superior to the iliac crest had no significant relationship to BIA, BMI or US.
This was the lowest WC measurement so it may be that measuring to low on the torso
may show no relationship to actual VAT. As a group sample mixed with males and
females, this study suggest using the WC site at the level of the umbilicus.
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In the male only samples, both groups overweight and obese BMI found WC2
having the highest US correlation with WC3 next followed by WC1. The correlation
with BIA was highly significant in all male groups with obese with WC1 having the
highest correlation (r = .900, p = < .01) in this study which agrees with Willis et al., 2007
who claim that the lowest palpable rib may be best for identifying cardiometabolic
disease risk based on VAT. These results are in disagreement with Segal et al., 1988 who
claim being obese or severely obese is a limitation when using BIA because it has
consistently overestimated lean body mass in severely obese people. For a dominant
male sample maybe a lower WC measurement would be better. This could be due to
males tending to develop android obesity.
In the all female group only WC1 and WC2 had relationships to BMI, BIA or US.
WC3 had no significant relationship to any of the variables as a group. BMI should be
paired with WC1 due to the significant and high correlation (r = .933, p = < .01) to BMI.
WC3 had no relationship to BIA or US for the all female group so its possible that higher
WC sites may be more useful in this population. This could be due to the way females
store fat. WC at the umbilicus (WC2) had the strongest significant but moderate
correlation (r = .631, p = < .01) to US. When the females were broken down into the
overweight and obese BMI, BMI and WC1 continued to have the strongest correlations (r
= .740, p = < .01) and BIA ((r = .507, p = < .05). However, for US, WC2 had the
strongest and significant relationship (r = .674, p = < .01). The obese group for females
WC1 had the highest and significant relationships to BMI (r = .927, p = < .01) and BIA (r
= .721, p = < .01) while US had no relationship to any of the WC sites. This could be due
to body fat distribution being a gynoid type.
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Future Research directions
Future research should include a larger sample size with age and possibly
ethnicity as additional variables to see if the correlations are strengthened or weakened.
This research only included the three main WC sites so midway between the lowest rib
and the iliac crest and minimal waist should be investigated as well. The gender
difference in the present study suggests future research to determine if different WC sites
should be researched for males and females. For men it appears as weight is gained
lower WC sites should be used. Overweight and obese males had stronger relationships
at the lowest WC site used. Studies looking at overweight and especially obese females
should look into below the lowest palpable rib; midpoint between the lowest rib and the
iliac crest and minimal waist to see what relationships may exist. It is possible for this
group that higher up on the torso maybe better to use. This study also combined all levels
of obesity into a single group. Since US found no relationship to any site it is possible
that the different levels of obesity in males and females need to be conducted to see what
kind of relationships may exist.
Conclusion
The results of this study show that WC at the level of the umbilicus (WC2) with
or without BMI is recommended for this college student sample of males and females
ages 18-55 years old, due to the relationships with BMI, BIA and US that were observed.
There was a gender effect and males may require lower WC sites and females may
require higher WC sites. This gender effect may possibly be due to body fat distribution
differences. To add to or strengthen these results, it seems worthy to conduct a larger
scale study to include the various levels of obesity with all five WC sites and to also
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include ethnicity as well. This chapter presented a discussion of the results and how they
relate to the current literature. This research is a step forward towards providing a
standard for a WC protocol.
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Appendix 1: IRB Approval
To:

Austin Nelson, Department of Physical Education, Health and Recreation,
200PEB

From:
Research

Sarah Keller, Chair, Institutional Review Board for Human Subjects

Date:

December 31, 2015

Subject:

Expedited IRB Review of Determining the Relationship Between Three
Waist Circumference Measures, BIA, Trunk Percent Fat, and Ultrasound
Abdominal Fat Depth (HS-4936)

The Institutional Review Board for Human Subjects' Expedited Review Committee has
reviewed your proposal to see if there is a correlation between any of the three main WC
sites and either US or BIA.
The Committee has approved your proposal; a signed, approved copy of your application
is enclosed.
Human subjects research approval granted by the IRB is valid for one year from the date
of approval, to December 31, 2016. If research is to continue, with no substantial
changes, beyond that date, a renewal of IRB approval must be obtained prior to
continuation of the project (contact OGRD for procedure). If, subsequent to initial
approval, a research protocol requires minor changes, the OGRD should be notified of
those changes. Any major departures from the original proposal must be approved by the
appropriate review process before the protocol may be altered. A Change of Protocol
application must be submitted to the IRB for any substantial change in the protocol. The
Director, Grant and Research Development, or the Chair of the IRB will determine
whether or not the research must then be resubmitted for approval.
If you have additional questions please contact me at 359-7039; fax 359-2474: email:
skeller@ewu.edu. It would be helpful if you would refer to HS-4936 if there were further
correspondence as we file everything under this number. Thank you.
cc:

C.Brewer
R.Galm
W.Repovich
Graduate Office
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Appendix 2: Informed Consent
Informed consent form
“Determining the relationship between three waist circumference measures,
BIA trunk percent fat, and ultrasound abdominal fat depth”
In partial fulfillment of Master’s Thesis for Austin Nelson
Principal Investigator
Austin Nelson
1110 E. Cozza Dr Spokane,WA 99208
253-250-1219
ausnelson@comcast.net

Responsible Project Investigator
Wendy Repovich, Ph.D., FACSM
Physical Education, Health and Recreation Dept.
200 Physical Education Bldg.
Cheney, WA 99004-2476

Purpose and Benefits
Obesity and being overweight have several health implications such as risk for type 2
diabetes, cardiovascular disease, hypertension, high cholesterol, and certain forms of
cancer that result in premature death. Various methods have been used to assess risk, but
there has been no standardization of measurement of the waist circumference.
identifying obese and overweight people is important. The purpose of this study is to
determine the relationship between any of the three main waist circumference sites,
ultrasound measures of abdominal fat depths and Bioelectrical Impedance measure of
trunk percent fat to recommend a preferred measurement location.
Procedures
You will come to the Human Performance Lab at Eastern Washington University
where the following measurements will be taken. You will need to wear clothing that
will allow measurements of the abdomen.
1) Your height and weight will be measured using a physician’s scale with a
stadiometer to determine BMI.
2) Your waist circumference will be measured at three sites using a Gulick
measuring tape. The sites are superior to the iliac crest, level of the umbilicus,
and right below the lowest palpable rib.
3) The body fat percentage of your abdomen will be measured using bioelectrical
impedance analysis on a machine (resembling a scale) that uses a measure of
electrical impedance to estimate % body fat of the trunk.
4) Your total, visceral, and subcutaneous fat depths will be measured by an
ultrasound machine. A dime-sized amount of ultrasound gel will be placed on the
wand which will then be placed on the abdomen to the right of the umbilicus and
the scan will be performed by moving the wand 7-10 cm across the skin toward
the right hip.
Risk, Stress or Discomfort
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There is minimal risk of an allergic reaction to the ultrasound gel. All equipment will
be cleaned before and after each use. Body composition results may cause some stress
for individuals. Lifestyle counseling will be available for my benefit at the time of
the measurements if needed.
Inquiries
Any questions about the procedures used in this study are encouraged. If you have
any concerns, questions, or would like more information please contact Wendy
Repovich or Austin Nelson prior to signing the informed consent form. We can be
reached at (509)359-7960; wrepovich@ewu.edu and (253) 250-1219
ausnelson@comcast.net respectively.
Other Information
If you have any concerns about your rights as a participant in this research or any
complaints you wish to make, you may contact Ruth Galm, Human Protection
Administrator, (509) 359-6567 or rgalm@ewu.edu

Signature of Principal Investigator

Date

Subject Statement
My participation in this study is completely voluntary. I am free to refuse participation
and to stop at any point in this study. I understand the study procedures that I will
perform, and the possible risks that go along with the testing and training. Knowing all
of the risks and discomforts, and being allowed to ask questions that have been answered
to my satisfaction, I consent to take part in this study. I am not waiving my legal rights
by signing this form. I understand I will receive a signed copy of this consent form.

Signature of Participant

Date
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Appendix 3:
Data Collection Sheet
________________________
Name
Male or Female (circle)
_________
Height
_________
Weight
_________
BMI score
__________
BIA % trunk fat
WC site 1______________ 2______________3_______________

Ultrasound VAT depth –
Notes -
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